Elevance Health Inc (ELV)

Return on assets (ROA)

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net income (ttm)	US$ in thousands	5,980,000	6,418,000	6,691,000	6,244,000	6,002,000	6,123,000	6,447,000	6,244,000	6,019,000	6,167,000	6,056,000	6,207,000	6,095,000	5,521,000	4,241,000	4,716,000	4,572,000	4,955,000	5,916,000	4,779,000
Total assets	US$ in thousands	116,889,000	116,533,000	112,988,000	111,894,000	108,928,000	110,478,000	109,168,000	109,040,000	102,755,000	103,026,000	100,877,000	100,486,000	97,460,000	98,060,000	96,097,000	95,683,000	86,615,000	86,574,000	87,976,000	82,399,000
ROA		5.12%	5.51%	5.92%	5.58%	5.51%	5.54%	5.91%	5.73%	5.86%	5.99%	6.00%	6.18%	6.25%	5.63%	4.41%	4.93%	5.28%	5.72%	6.72%	5.80%

December 31, 2024 calculation

ROA = Net income (ttm) ÷ Total assets
= $5,980,000K ÷ $116,889,000K
= 5.12%

Elevance Health Inc's return on assets (ROA) has fluctuated over the reported periods, ranging from a low of 4.41% in June 2021 to a high of 6.72% in June 2020. The ROA generally remained above 5% for most of the periods, indicating that the company is effectively utilizing its assets to generate profits.

There was a slight downward trend observed from the peak in June 2020 until December 2024, where the ROA decreased to 5.12%. This decreasing trend suggests that the company's ability to generate profits from its assets may have slightly declined over time.

Overall, Elevance Health Inc's ROA performance demonstrates the company's efficiency in generating profits relative to its total assets, but management may need to address the declining trend to ensure sustained profitability and asset utilization efficiency in the future.